TY - JOUR
T1 - Viral G Protein-Coupled Receptors Encoded by β- and γ-Herpesviruses
AU - Rosenkilde, Mette M.
AU - Tsutsumi, Naotaka
AU - Knerr, Julius M.
AU - Kildedal, Dagmar F.
AU - Garcia, K. Christopher
PY - 2022/9/29
Y1 - 2022/9/29
N2 - Herpesviruses are ancient large DNA viruses that have exploited gene capture as part of their strategy to escape immune surveillance, promote virus spreading, or reprogram host cells to benefit their survival. Most acquired genes are transmembrane proteins and cytokines, such as viral G protein-coupled receptors (vGPCRs), chemokines, and chemokine-binding proteins. This review focuses on the vGPCRs encoded by the human β- and γ-herpesviruses. These include receptors from human cytomegalovirus, which encodes four vGPCRs: US27, US28, UL33, and UL78; human herpesvirus 6 and 7 with two receptors: U12 and U51; Epstein-Barr virus with one: BILF1; and Kaposi's sarcoma-associated herpesvirus with one: open reading frame 74, ORF74. We discuss ligand binding, signaling, and structures of the vGPCRs in light of robust differences from endogenous receptors. Finally, we briefly discuss the therapeutic targeting of vGPCRs as future treatment of acute and chronic herpesvirus infections.
AB - Herpesviruses are ancient large DNA viruses that have exploited gene capture as part of their strategy to escape immune surveillance, promote virus spreading, or reprogram host cells to benefit their survival. Most acquired genes are transmembrane proteins and cytokines, such as viral G protein-coupled receptors (vGPCRs), chemokines, and chemokine-binding proteins. This review focuses on the vGPCRs encoded by the human β- and γ-herpesviruses. These include receptors from human cytomegalovirus, which encodes four vGPCRs: US27, US28, UL33, and UL78; human herpesvirus 6 and 7 with two receptors: U12 and U51; Epstein-Barr virus with one: BILF1; and Kaposi's sarcoma-associated herpesvirus with one: open reading frame 74, ORF74. We discuss ligand binding, signaling, and structures of the vGPCRs in light of robust differences from endogenous receptors. Finally, we briefly discuss the therapeutic targeting of vGPCRs as future treatment of acute and chronic herpesvirus infections.
KW - broad-spectrum ligand binding
KW - chemokine receptor
KW - G protein signaling
KW - GPCR structure
KW - herpesvirus
UR - http://www.scopus.com/inward/record.url?scp=85138507259&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85138507259&partnerID=8YFLogxK
U2 - 10.1146/annurev-virology-100220-113942
DO - 10.1146/annurev-virology-100220-113942
M3 - Review article
C2 - 35671566
AN - SCOPUS:85138507259
SN - 2327-056X
VL - 9
SP - 329
EP - 351
JO - Annual Review of Virology
JF - Annual Review of Virology
IS - 1
ER -